Clinical Trial Update: Evaluation of the Safety and Efficacy of Insulin Glargine 300 U/ml (Gla-300) in Insulin-naïve Patients With Type 2 Diabetes Mellitus Uncontrolled on Oral Antihyperglycemic Drugs [Phase 4]

View source ↗

Summary

Phase 4 study evaluating the safety and efficacy of insulin glargine 300 U/mL (Gla-300) in insulin-naïve adults with type 2 diabetes uncontrolled on oral antihy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• TOUJEO (insulin glargine)

Snippet

Sponsor: Sanofi | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: COMPLETED